Jones Soda Engages Liolios to Lead New Strategic Investor Relations Program
Apr 25, 2018 20:05 pm UTC| Business
SEATTLE, April 25, 2018 -- Jones Soda Co. (the “Company”) (OTCQB:JSDA), a leader in the craft soda category and known for its unique branding and innovative marketing, has engaged Liolios Group to lead a new strategic...
Cardlytics Announces Timing of Its First Quarter 2018 Financial Results Conference Call and Webcast
Apr 25, 2018 20:05 pm UTC| Business
ATLANTA, April 25, 2018 -- Cardlytics, Inc., (NASDAQ:CDLX), a purchase intelligence platform that helps make marketing more relevant and measurable, today announced that its first quarter 2018 financial results will be...
CM Finance Schedules Earnings Release of Third Quarter Ended March 31, 2018
Apr 25, 2018 20:05 pm UTC| Business
NEW YORK, April 25, 2018 -- CM Finance Inc (NASDAQ:CMFN) (the “Company”) today announced that it will release its financial results for the quarter ended March 31, 2018 on Tuesday, May 8, 2018 after the close of the...
LifeVantage to Announce Third Quarter Fiscal Year 2018 Results on May 9, 2018
Apr 25, 2018 20:05 pm UTC| Business
SALT LAKE CITY, April 25, 2018 -- LifeVantage Corporation (Nasdaq:LFVN) announced today that it will release financial results for its third quarter ended March 31, 2018, after the stock market closes on Wednesday, May...
Apr 25, 2018 20:05 pm UTC| Business
MCLEAN, Va., April 25, 2018 -- Gladstone Investment Corporation (NASDAQ:GAIN) (the “Company”) announced today that it plans to report earnings for the fourth quarter and year ended March 31, 2018 after the stock market...
Apr 25, 2018 20:04 pm UTC| Business
RALEIGH, N.C., April 25, 2018 -- PRA Health Sciences, Inc. (NASDAQ:PRAH) today announced that Linda Baddour, Executive Vice President and Chief Financial Officer will retire from her position as CFO, effective May 1,...
Calithera Biosciences Announces CB-839 Abstracts Accepted for Presentation at ASCO 2018
Apr 25, 2018 20:03 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., April 25, 2018 -- Calithera Biosciences, Inc. (Nasdaq:CALA), a clinical stage biotechnology company focused on the development of novel cancer therapeutics, today announced that three...